Raymond J. Henley Iii

Array ( [id] => 4147661 [patent_doc_number] => 06063802 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Ondansetron freeze-dried dosage form compositions for oral administration' [patent_app_type] => 1 [patent_app_number] => 9/238165 [patent_app_country] => US [patent_app_date] => 1999-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2129 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063802.pdf [firstpage_image] =>[orig_patent_app_number] => 238165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945773 [patent_doc_number] => 05998364 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Component B as cicatrizant' [patent_app_type] => 1 [patent_app_number] => 9/171659 [patent_app_country] => US [patent_app_date] => 1999-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11186 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998364.pdf [firstpage_image] =>[orig_patent_app_number] => 171659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049260 [patent_doc_number] => 05968960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism' [patent_app_type] => 1 [patent_app_number] => 9/231413 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10409 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968960.pdf [firstpage_image] =>[orig_patent_app_number] => 231413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187239 [patent_doc_number] => 06093711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Enteric-coated chromium picolinate compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/228701 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3525 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093711.pdf [firstpage_image] =>[orig_patent_app_number] => 228701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103360 [patent_doc_number] => 06100250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Enteric-coated chromium polynicotinate compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/229463 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3526 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100250.pdf [firstpage_image] =>[orig_patent_app_number] => 229463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185057 [patent_doc_number] => 06150401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Use of MEK1 inhibitors as protective agents against damage due to ischemia' [patent_app_type] => 1 [patent_app_number] => 9/226080 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7256 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150401.pdf [firstpage_image] =>[orig_patent_app_number] => 226080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180075 [patent_doc_number] => 06037373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1' [patent_app_type] => 1 [patent_app_number] => 9/147465 [patent_app_country] => US [patent_app_date] => 1999-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1310 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037373.pdf [firstpage_image] =>[orig_patent_app_number] => 147465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147746 [patent_doc_number] => 06063808 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Methods and compositions for treating urinary incontinence using enantiomerically enriched (S,S)-glycopyrrolate' [patent_app_type] => 1 [patent_app_number] => 9/214169 [patent_app_country] => US [patent_app_date] => 1998-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6838 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063808.pdf [firstpage_image] =>[orig_patent_app_number] => 214169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156799 [patent_doc_number] => 06103748 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Method of treating an autoimmune disorder' [patent_app_type] => 1 [patent_app_number] => 9/223069 [patent_app_country] => US [patent_app_date] => 1998-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2709 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103748.pdf [firstpage_image] =>[orig_patent_app_number] => 223069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099693 [patent_doc_number] => 06048891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of natriuretic disease' [patent_app_type] => 1 [patent_app_number] => 9/215608 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14958 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048891.pdf [firstpage_image] =>[orig_patent_app_number] => 215608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132461 [patent_doc_number] => 06034108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Method for treating mental retardation' [patent_app_type] => 1 [patent_app_number] => 9/202519 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1492 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034108.pdf [firstpage_image] =>[orig_patent_app_number] => 202519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4135418 [patent_doc_number] => 06147236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Preparation of sterol and stanol-esters' [patent_app_type] => 1 [patent_app_number] => 9/211978 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3402 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147236.pdf [firstpage_image] =>[orig_patent_app_number] => 211978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936850 [patent_doc_number] => 05972882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Treatment of polycystic kidney disease using vasopressin V.sub.2 receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/211396 [patent_app_country] => US [patent_app_date] => 1998-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 11005 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972882.pdf [firstpage_image] =>[orig_patent_app_number] => 211396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097581 [patent_doc_number] => 06099870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Methods for improving the health of hair and scalp' [patent_app_type] => 1 [patent_app_number] => 9/208948 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4367 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099870.pdf [firstpage_image] =>[orig_patent_app_number] => 208948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220475 [patent_doc_number] => 06040322 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Medicaments for ameliorating endothelial cell activation' [patent_app_type] => 1 [patent_app_number] => 9/194950 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2914 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 299 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040322.pdf [firstpage_image] =>[orig_patent_app_number] => 194950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241141 [patent_doc_number] => 06136348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Compound and method for degrading amino acids' [patent_app_type] => 1 [patent_app_number] => 9/205997 [patent_app_country] => US [patent_app_date] => 1998-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7964 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136348.pdf [firstpage_image] =>[orig_patent_app_number] => 205997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3919985 [patent_doc_number] => 05945107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Compositions and methods for weight reduction' [patent_app_type] => 1 [patent_app_number] => 9/206081 [patent_app_country] => US [patent_app_date] => 1998-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2512 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945107.pdf [firstpage_image] =>[orig_patent_app_number] => 206081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946858 [patent_doc_number] => 05998435 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis' [patent_app_type] => 1 [patent_app_number] => 9/194620 [patent_app_country] => US [patent_app_date] => 1998-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 3785 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998435.pdf [firstpage_image] =>[orig_patent_app_number] => 194620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4287826 [patent_doc_number] => 06211143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Preparation and method for increasing cartilaginous mass of joints in a mammal' [patent_app_type] => 1 [patent_app_number] => 9/194696 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2809 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211143.pdf [firstpage_image] =>[orig_patent_app_number] => 194696 [rel_patent_id] =>[rel_patent_doc_number] =>)